Cancer Deaths Decline as New Cases Rise

Why Are Cancer Deaths Falling While New Cases Are Rising?

Incidence and mortality measure different parts of the cancer burden. Incidence counts newly diagnosed cancers, whereas mortality records deaths attributed to cancer. An aging population can produce more diagnoses because cancer risk generally increases with age, while age-adjusted mortality may decline through prevention, earlier detection, and improved treatment.

The divergence therefore does not mean cancer is becoming unimportant. Rising incidence can increase demand for diagnostic services, oncology care, long-term surveillance, and support for treatment-related effects. National trends can also conceal substantial differences by cancer type, age, race, socioeconomic circumstances, and geographic access to screening and specialist care.

How Has Progress Against Lung Cancer Reduced Cancer Mortality?

Lung cancer has historically caused more cancer deaths in the United States than any other cancer, so improvements in this disease can meaningfully affect overall mortality. Long-term reductions in cigarette smoking remain central, while low-dose computed tomography can identify some lung cancers earlier in people at high risk who meet screening criteria.

Treatment has also changed through molecular testing, targeted drugs, immunotherapy, more precise radiation, and improved surgery and supportive care. These advances do not benefit every patient equally, and lung cancer can still be difficult to cure after it has spread. Expanding smoking-cessation support and appropriate screening remains essential alongside therapeutic innovation.

What Do the Cancer Trends Mean for Prevention and Screening?

People can reduce cancer risk by avoiding tobacco, limiting alcohol, maintaining physical activity, managing excess body weight, protecting skin from ultraviolet radiation, and receiving recommended vaccines against cancer-associated infections such as human papillomavirus and hepatitis B. These measures lower risk but cannot prevent every cancer.

Screening should follow evidence-based recommendations because benefits and harms vary by age and individual risk. Patients should discuss breast, cervical, colorectal, and lung cancer screening with a qualified clinician rather than relying on a single national trend. New symptoms—including unexplained bleeding, a persistent lump, progressive difficulty swallowing, or unexplained weight loss—still warrant medical assessment even after a recent normal screening result.